Although studies using supra-physiological concentrations of DTX (75 nM) have also documented decreased p-AKT levels [48], our current investigations using physiologic concentrations of DTX (10 nM) clearly suggested that simultaneous targeting of both ER-stress and AKT pathways can disable the early induction of survival signaling in cancer cells [49]. This evidence concerns the gene AKT1 and cancer.